migalastat has been researched along with galactose in 6 studies
| Studies (migalastat) | Trials (migalastat) | Recent Studies (post-2010) (migalastat) | Studies (galactose) | Trials (galactose) | Recent Studies (post-2010) (galactose) |
|---|---|---|---|---|---|
| 143 | 14 | 89 | 18,988 | 193 | 4,605 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA | 1 |
| Aguilar-Moncayo, M; Garcia Fernandez, JM; Higaki, K; Mena-Barragán, T; Nanba, E; Ohto, U; Ortiz Mellet, C; Shimizu, T; Suzuki, H; Suzuki, Y | 1 |
| Kolter, T; Wendeler, M | 1 |
| Ochi, T; Ohto, U; Satow, Y; Shimizu, T; Usui, K; Yuki, K | 1 |
| Clark, NE; Garman, SC; Guce, AI; Rogich, JJ | 1 |
| Arévalo-Gómez, A; Besada, P; Fernández-Martín, J; Gallardo-Gómez, M; Ortolano, S; Pantano, S; Patiño-Álvarez, L; Pérez-Márquez, T; Ruz-Zafra, A; Silva-López, C; Terán, C | 1 |
2 review(s) available for migalastat and galactose
| Article | Year |
|---|---|
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship | 2013 |
Chemical chaperones--a new concept in drug research.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Animals; Enzyme Stability; Fabry Disease; Galactose; Gaucher Disease; Glycoside Hydrolases; Humans; Imino Sugars; Molecular Weight; Piperidines; Protein Conformation; Protein Folding | 2003 |
4 other study(ies) available for migalastat and galactose
| Article | Year |
|---|---|
Structural basis of pharmacological chaperoning for human β-galactosidase.
Topics: 1-Deoxynojirimycin; beta-Galactosidase; Catalytic Domain; Crystallography, X-Ray; Cyclohexenes; Enzyme Inhibitors; Enzyme Stability; Gangliosidosis, GM1; Hexosamines; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Imino Sugars; Inositol; Kinetics; Models, Molecular; Molecular Structure; Mucopolysaccharidosis IV; Mutation; Protein Structure, Tertiary; Static Electricity; Structure-Activity Relationship | 2014 |
Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.
Topics: 1-Deoxynojirimycin; beta-Galactosidase; Crystallography, X-Ray; G(M1) Ganglioside; Galactose; Gangliosidosis, GM1; Humans; Hydrolysis; Keratan Sulfate; Lysosomes; Models, Molecular; Mucopolysaccharidosis IV; Mutation; Protein Structure, Tertiary | 2012 |
The molecular basis of pharmacological chaperoning in human α-galactosidase.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Binding Sites; Crystallography, X-Ray; Fabry Disease; Galactose; Humans; Hydrogen-Ion Concentration; Mutagenesis, Site-Directed; Phase Transition; Protein Structure, Tertiary; Protein Unfolding; Transition Temperature | 2011 |
The New Pharmacological Chaperones PBXs Increase α-Galactosidase A Activity in Fabry Disease Cellular Models.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Drug Stability; Enzyme Replacement Therapy; Fabry Disease; Galactose; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Leukocytes, Mononuclear; Models, Biological; Models, Molecular; Mutation; Protein Conformation | 2021 |